<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<?OntoDPSData docID="3372769" markupID="2092790" OntoTechnologyVersion="3.59.92.0"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:BasicEntity="http://www.abbyy.com/ns/BasicEntity#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:Aux="http://www.abbyy.com/ns/Aux#">
	<BasicEntity:MoneySimplified rdf:nodeID="bnode931AAAD6-8922-4109-AD58-08996D1F2CBB">
		<BasicEntity:ms_major_currency xml:lang="en-US">€</BasicEntity:ms_major_currency>
		<BasicEntity:ms_major_amount xml:lang="en-US">28700000</BasicEntity:ms_major_amount>
	</BasicEntity:MoneySimplified>
	<Aux:TextAnnotations rdf:nodeID="bnode04BB47A6-B2BB-440E-B2CA-111D2868BD2E">
		<Aux:document_text xml:lang="en-US">Lastly, I find it essential to underscore that BioAlliance Pharma's growth strategy is also based on human capital, on the know-how and experience of its teams in developing and registering products, as we again demonstrated as recently as late 2011 by filing the registration application in Europe forSitavir®/Sitavig®.  This growth strategy is based on a healthy financial position at end-2011. Could you elaborate on this?  J.G.: At the end of 2011 BioAlliance Pharma had €28.7 million in cash, after being significantly strengthened by the financing round completed in summer 2011, and for which we thank our shareholders for their active participation. This level of cash will, among other things, allow us to begin the decisive Phase III of clinical development for our product Livatag®.</Aux:document_text>
		<Aux:annotation>
			<Aux:InstanceAnnotation rdf:nodeID="bnode35BDC2F3-239C-488B-9946-54E5BE237FED">
				<Aux:annotation_start rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">475</Aux:annotation_start>
				<Aux:annotation_end rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">488</Aux:annotation_end>
				<Aux:instance rdf:nodeID="bnode931AAAD6-8922-4109-AD58-08996D1F2CBB"/>
			</Aux:InstanceAnnotation>
		</Aux:annotation>
		<Aux:annotation>
			<Aux:PropertyAnnotation rdf:nodeID="bnode5C010810-7C8C-4B4C-9FF3-18866A925711">
				<Aux:annotation_start rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">475</Aux:annotation_start>
				<Aux:annotation_end rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">476</Aux:annotation_end>
				<Aux:instance rdf:nodeID="bnode931AAAD6-8922-4109-AD58-08996D1F2CBB"/>
				<Aux:property_name xml:lang="en-US">http://www.abbyy.com/ns/BasicEntity#ms_major_currency</Aux:property_name>
				<Aux:property_value xml:lang="en-US">€</Aux:property_value>
			</Aux:PropertyAnnotation>
		</Aux:annotation>
		<Aux:annotation>
			<Aux:PropertyAnnotation rdf:nodeID="bnode27CBFFE3-4217-4309-8061-52FEBB9C0291">
				<Aux:annotation_start rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">476</Aux:annotation_start>
				<Aux:annotation_end rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">488</Aux:annotation_end>
				<Aux:instance rdf:nodeID="bnode931AAAD6-8922-4109-AD58-08996D1F2CBB"/>
				<Aux:property_name xml:lang="en-US">http://www.abbyy.com/ns/BasicEntity#ms_major_amount</Aux:property_name>
				<Aux:property_value xml:lang="en-US">28700000</Aux:property_value>
			</Aux:PropertyAnnotation>
		</Aux:annotation>
	</Aux:TextAnnotations>
</rdf:RDF>